Author details

Full Name

Ruth Tal-Singer

Affiliation

ORCID

Career Start Year

1989

Papers

218

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36283827	Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial.	Thorax	2023
37749248	Author Correction: Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk.	Nat Genet	2023
37316306	Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA.		2023
37236628	An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials.		2023
37207649	Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease.	Cell Host Microbe	2023
36741822	The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections.		2023
36400446	Evaluation of Over-the-Counter Portable Oxygen Concentrators Utilizing a Metabolic Simulator.	Respiratory Care	2023
36419950	A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study.	International Journal of COPD	2022
35970539	Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease.	Thorax	2022
35916275	Long-term trends of COPD mortality: Gaps and opportunities.	Respirology	2022
35715807	Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies.	Respir Res	2022
35482251	Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective.	Advances in Therapy	2022
35018752	A Conceptual Framework for Use of Increased Endurance Time During Constant Work Rate Cycle Ergometry as a Patient-Focused Meaningful Outcome in COPD Clinical Trials.	Chronic Obstructive Pulmonary Diseases	2022
34739356	Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease.	Am J Respir Crit Care Med	2022
34672872	Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.	Am J Respir Crit Care Med	2022
36477530	Genetic diversity fuels gene discovery for tobacco and alcohol use.	Nature	2022
33780603	Development of ResperciseÂ® a Digital Application for Standardizing Home Exercise in COPD Clinical Trials.	Chronic Obstructive Pulmonary Diseases	2021
33591891	Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts.	Radiology	2021
33334936	A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.	European Respiratory Journal	2021
33332995	Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.	Am J Respir Crit Care Med	2021
33303557	Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort.	Eur Respir J	2021
33291190	New Adopters of Telemedicine During the Coronavirus-19 Pandemic in Respondents to an Online Community Survey: The Case for Access to Remote Management Tools for Individuals with Chronic Obstructive Pulmonary Disease.	Chronic Obstructive Pulmonary Diseases	2021
32972986	A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD.	European Respiratory Journal	2021
32894757	Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease.	Age and Ageing	2021
32353489	The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.	Journal of Allergy and Clinical Immunology	2021
34616836	Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial.	ERJ Open Research	2021
34612086	A rapidly changing understanding of COPD: World COPD Day from the COPD Foundation.	American Journal of Physiology - Lung Cellular and Molecular Physiology	2021
34588775	Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.	International Journal of COPD	2021
34527722	Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale.	ERJ Open Res	2021
34523824	Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary disease.	J Cachexia Sarcopenia Muscle	2021
34476245	Quantitative F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD.	ERJ Open Research	2021
34433239	Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity.	Chronic Obstructive Pulmonary Diseases	2021
34217679	Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.	Chest	2021
34168442	A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design.	International Journal of COPD	2021
34168439	Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.	International Journal of COPD	2021
33906653	Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.	Respir Res	2021
33780868	Nighttime features derived from topic models for classification of patients with COPD.	Computers in Biology and Medicine	2021
31815521	Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.	American Journal of Respiratory and Critical Care Medicine	2020
33372069	Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study.	BMJ Open	2020
33263062	CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin.	ERJ Open Research	2020
33149694	Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene Study.	Clinical Epidemiology	2020
33123802	Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK.	Pharmaceutical Research	2020
33116463	Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.	International Journal of COPD	2020
33035747	Combining biomarkers of clot resolution and alveolar basement membrane destruction predicts mortality in the ECLIPSE COPD cohort.	Respiratory Medicine	2020
33032168	COPDCompEx: A novel composite endpoint for COPD exacerbations to enable faster clinical development.	Respiratory Medicine	2020
32948678	Consensus Recommendations on the Use of F-FDG PET/CT in Lung Disease.		2020
32731895	Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort.	Respiratory Research	2020
32719402	Multi-omic meta-analysis identifies functional signatures of airway microbiome in chronic obstructive pulmonary disease.	ISME J	2020
32664956	The sputum microbiome is distinct between COPD and health, independent of smoking history.	Respir Res	2020
32611352	Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD.	Respiratory Research	2020